Screener
Visteon VC Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Visteon in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The source filing: Visteon’s 10-Q, filed July 23, 2026.
- Filed
- Jul 23, 2026, 7:13 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001111335-26-000046
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Proceeds from the exercise of stock options | 8 | 3 |
| Contingent consideration payments | (7) | — |
| Other | (2) | — |
| Net cash used by financing activities | (77) | (38) |
| Effect of exchange rate changes on cash | 4 | 33 |
| Net increase (decrease) in cash, equivalents, and restricted cash | (123) | 45 |
| Cash, equivalents, and restricted cash at beginning of the period | 773 | 626 |
| Cash, equivalents, and restricted cash at end of the period | $650 | $671 |
Item 1.Condensed Consolidated Financial Statements
FAQ
- What is Visteon's cash & equivalents?
- Visteon (VC) reported cash & equivalents of $650M in Q2 2026.
- How has Visteon's cash & equivalents changed year-over-year?
- Visteon's cash & equivalents decreased by 3.1% year-over-year, from $671M to $650M.
- What is the long-term trend for Visteon's cash & equivalents?
- Over 5 years (2020 to 2025), Visteon's cash & equivalents has grown at a 9.1% compound annual growth rate (CAGR), from $500M to $773M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Visteon's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude